PGDx: Jamie Platt, Maggie Rougier-Chapman
Personal Genome Diagnostics has appointed Jamie Platt as chief operations officer, charged with overseeing firm's product and services operations and supporting the advancement and global impact of the PGDx Elio product line. Most recently, Platt served as COO at Inivata. She also held roles as VP of genomic solutions at MPLN and director of advanced sequencing at Quest Diagnostics. Platt serves on the boards of Pictor, Mobility Health Lab, and DxTerity Diagnostics. She earned her PhD in molecular & cellular biology from Oregon State University and completed post-doctoral studies at University of California at Berkeley.
The company has also appointed Maggie Rougier-Chapman as its senior VP and head of marketing and commercial strategy. Most recently, Rougier-Chapman served as head of oncology product management & strategy at Invitae, having joined the firm through its acquisition of ArcherDX, where she served as executive VP of commercial operations. Prior to that, she was VP of global marketing at Bionano Genomics; spent several years in management roles at Agilent Technologies’ diagnostics and genomics division; and held various commercial roles at Advanced Cell Diagnostics, Cogenics, Incyte Genomics, and Stratagene. Rougier-Chapman holds an MS in molecular cancer biology and a BS in biology with a certificate in genetics from Duke University.